NanoZymeX raises CHF 150,000

A University of Basel spin-off, NanoZymeX is developing a lipid nanoparticle platform to improve enzyme replacement therapies. The startup has secured CHF 150,000 from Venture Kick for preclinical studies and to prepare for scaled-up production.

Announced on
Round
Grant
Amount
CHF 150,000
Location
canton of Basel-Stadt
Sector
Biotech & life sciences

Investors

Preparing a similar round?

The diagnostic shows you the instruments and investors that fit your stage.

Start the diagnostic